The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenew Holdings Regulatory News (RNWH)

Share Price Information for Renew Holdings (RNWH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 940.00
Bid: 0.00
Ask: 950.00
Change: 0.00 (0.00%)
Spread: 10.00 (1.064%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 940.00
RNWH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

H1 Period End Trading Update

1 Apr 2020 07:00

RNS Number : 3111I
Renew Holdings PLC
01 April 2020
 

 

 

Renew Holdings plc

("Renew" or the "Group")

 

H1 Period End Trading Update

 

Renew (AIM: RNWH), the Engineering Services Group supporting UK infrastructure, announces an update on trading in advance of the interim results for the half year ended 31 March 2020.

 

The Board expects the Group's trading in the first half of the year to be in-line with market expectations. We are also pleased to confirm that the integration of Carnell, acquired in January 2020, is going well and its trading performance has been in line with our expectations.

 

The potential impact of Covid-19 on the Group's trading performance in the second half of the year is unclear at this stage. We remain, where safe to do so, operational across the majority of our sectors, but we are experiencing disruption in certain areas. In Rail and Highways, which account for the majority of our engineering activity, we are working closely with our public sector customers in areas designated critical to the Covid-19 response. In both cases there is a clear commitment and ongoing demand for our directly delivered maintenance and renewal services. Water and Telecommunications have also been designated 'critical sectors' and we remain operational here too, with key workers deployed across all network areas where we have framework contracts. Our services in civil nuclear have been disrupted with a temporary cessation of programmes at Sellafield and Springfields where both customers are developing plans for resumption of critical activities that will require our involvement. In total, approximately 80% of our activities are in areas deemed critical to the Covid-19 response.

 

Cash generation in the first half of the year has continued to be strong and the Group's net debt as at 31 March 2020 is anticipated to be between £15m-£17m. Included in this amount is the balance outstanding on the term loan used to fund the acquisition of QTS which was £17.5m. The Group recently re-financed its working capital facilities as part of the acquisition of Carnell in January 2020 and now has a revolving credit facility ("RCF") provided by HSBC & NatWest of £44.2m, expiring in January 2024. In addition, the Group has a £10m unsecured overdraft facility. As at 31 March 2020, we anticipate having headroom in our available facilities of approximately £55m plus a £15m uncommitted accordion facility on the RCF.

 

Since the escalation of the Covid-19 pandemic, the Board has been focussed on taking actions to preserve cash and protect liquidity in a way that does not compromise the long-term prospects of the business. These include deferral of all non-essential capital expenditure, a hiring freeze, cost reductions, deferral of VAT payments (£2.6m deferred in March), utilisation of the Government's Job Retention Scheme and a temporary 20% reduction in the salaries of the Board and senior management from 1 April 2020. In addition, the Board has decided to suspend payment of the interim dividend which would ordinarily have been paid to shareholders in July. We understand the importance of the dividend to our shareholders and will keep our dividend policy under review in the coming months.

 

The Board believe these actions to be prudent in light of the uncertain economic outlook, notwithstanding the non-discretionary nature of much of our work and the covenant strength of our customers. Nevertheless, at this stage we are not able to quantify the impact on our full year results and consequently the Board does not believe it would be appropriate to provide forward looking financial guidance until greater clarity returns.

 

Paul Scott, CEO commented:

 

"The health, safety and wellbeing of our people and all stakeholders impacted by our activities remains our highest priority. We have responded quickly and effectively to the incredible challenges of the Covid-19 pandemic and I am immensely proud of the reaction to this event by my colleagues and our entire workforce who remain fully committed to our mitigation measures.

 

"While we are experiencing interruption, the situation is continuously evolving and we have many defensive qualities which provide resilience in these unprecedented circumstances.

"Our strong trading performance in the period is reflective of the reliable long-term nature of the UK infrastructure markets in which we operate. We continue to work very closely with all of our customers and where we can satisfy the requirements of Public Health England guidance we are delivering essential network services that the UK Government has classified as critical to the Covid-19 response.

 

"Despite the unique challenges the country is currently facing, we are well placed to play a significant role in the long- term opportunities that will emerge for UK infrastructure services, a sector that will play an important role in rebuilding our economy."

 

 

Enquiries:

 

Renew Holdings plc

Tel: 0113 281 4200

Paul Scott, CEO

 

Sean Wyndham-Quin, CFO

 

 

 

Numis Securities Limited (Nominated Adviser & Broker)

Tel: 020 7260 1000

Stuart Skinner/ Kevin Cruickshank

 

 

 

Walbrook PR

Tel: 020 7933 8780 or renew@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

 

 

 

 

    

 

About Renew Holdings plc

 

Engineering Services, which accounts for over 90% of Group revenue and over 95% of operating profit, focuses on the key markets of Infrastructure, Energy (including Nuclear) and Environmental, which are largely governed by regulation and benefit from non-discretionary spend with long-term visibility of committed funding.

 

Specialist Building focuses on the High Quality Residential and science markets in London and the Home Counties.

 

For more information please visit the Renew Holdings plc website: www.renewholdings.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDXLUXDGGB
Date   Source Headline
9th Apr 20247:00 amRNSAcquisition of Route One
2nd Apr 20247:00 amRNSH1 Update, Directorate Change & Notice of Results
28th Feb 20247:59 amRNSHolding(s) in Company
30th Jan 202411:39 amRNSResult of AGM
30th Jan 20247:00 amRNSAGM Statement
21st Dec 202310:29 amRNSHolding(s) in Company
21st Dec 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Dec 202311:47 amRNSIssue of Equity
19th Dec 20235:12 pmRNSExercise of Options
8th Dec 20231:38 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSFinal Results
7th Nov 202311:00 amRNSNotice of Results
27th Oct 20237:00 amRNSAcquisition of TIS
2nd Oct 20237:00 amRNSYear End Trading Update
25th Sep 20233:33 pmRNSHolding(s) in Company
4th Sep 20233:57 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
15th Jun 20233:16 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSH1 Trading Update & Notice of Results
21st Mar 202312:07 pmRNSDirector/PDMR Shareholding
10th Mar 20237:00 amRNSIssue of Equity & Director Dealing
1st Feb 202312:20 pmRNSResult of AGM
1st Feb 20237:00 amRNSAGM Statement
10th Jan 20231:39 pmRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector/PDMR Shareholding
22nd Dec 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
21st Dec 20227:00 amRNSDirector/PDMR Shareholding
8th Dec 202212:16 pmRNSDirector/PDMR Shareholding
29th Nov 20227:00 amRNSAcquisition of Enisca
29th Nov 20227:00 amRNSFinal Results
10th Nov 20227:00 amRNSNotice of Results
1st Nov 20227:00 amRNSAppointment of Non-Executive Director
3rd Oct 20227:00 amRNSYear End Trading Update
29th Sep 20224:24 pmRNSDirector/PDMR Shareholding
21st Sep 202212:40 pmRNSDirector/PDMR Shareholding
13th Sep 20224:19 pmRNSDirector / PDMR Shareholding
15th Aug 20227:00 amRNSAppointment of Non-Executive Director
17th May 20227:00 amRNSDirectorate Change
17th May 20227:00 amRNSHalf-year Report
1st Apr 20227:00 amRNSH1 Trading Update
10th Mar 20227:00 amRNSDirectorate Change
26th Jan 202212:02 pmRNSResult of AGM
26th Jan 20227:00 amRNSAGM Statement
19th Jan 20225:09 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSAnnual Report & Accounts and Notice of AGM
16th Dec 20217:00 amRNSIssue of Equity & Director Dealing
9th Dec 20217:00 amRNSDirectorate Change
9th Dec 20217:00 amRNSFinal Results
6th Dec 20215:01 pmRNSFinal Results Revised Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.